Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: A review by D. A. Laksemi et al.









Veterinary World, EISSN: 2231-0916 716
Veterinary World, EISSN: 2231-0916
Available at www.veterinaryworld.org/Vol.13/April-2020/15.pdf
REVIEW ARTICLE
Open Access
Opportunistic parasitic infections in patients with human 
immunodeficiency virus/acquired immunodeficiency syndrome: A 
review
D. A. Laksemi1 , L. T. Suwanti2,3 , M.  Mufasirin2,3 , K. Suastika4 and M. Sudarmaja1
1. Department of Parasitology, Faculty of Medicine, Udayana University, Bali, Indonesia; 2. Department of Parasitology,
Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia; 3. Institute of Tropical Disease, 
Universitas Airlangga, Surabaya, East Java, Indonesia; 4. Department of Internal Medicine, Faculty of Medicine, Udayana 
University, Bali, Indonesia.
Corresponding author: D. A. Laksemi, e-mail: srilaksemi@unud.ac.id
Co-authors: LTS: lucia-t-s@fkh.unair.ac.id, MM: mufasirin@fkh.unair.ac.id, KS: ksuas@unud.ac.id,  
MS: made_sudarmaja@unud.ac.id
Received: 22-11-2019, Accepted: 02-03-2020, Published online: 17-04-2020
doi: www.doi.org/10.14202/vetworld.2020.716-725 How to cite this article: Laksemi DA, Suwanti LT, Mufasirin M, 
Suastika K, Sudarmaja M (2020) Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired 
immunodeficiency syndrome: A review, Veterinary World, 13(4): 716-725.
Abstract
The number of human immunodeficiency virus (HIV) cases increases annually, and Indonesia has become the country with 
the fastest HIV/acquired immunodeficiency syndrome (AIDS) epidemic spread among the five Southeast Asian countries. 
Indonesia entered the critical phase of HIV/AIDS infections after 5 out of the 33 provinces, namely, Papua, Jakarta, Bali, 
West Java, and East Java, reported HIV/AIDS epidemic since 2004. In AIDS pathophysiology and immune-suppression are 
severe, thus, opportunistic intestinal parasitic infections that cause diarrhea in HIV infection may be fatal. Several studies 
have suggested that Cryptosporidium parvum, Isospora belli, and Blastocystis hominis are the most common intestinal 
protozoan parasites categorized as AIDS associated illness. Diarrhea caused by parasites is considerably suspected in the 
cases of chronic and persistent diarrhea in adults, in an era of increasing HIV/AIDS cases nowadays. The present review 
highlights the current advances in etiologic agents of HIV/AIDS opportunistic infections among countries, epidemiology 
and prevalence, lifecycle, risk factors, examination methods, and treatment.
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Introduction
Opportunistic parasitic infections are infections 
of parasite species that are mild or asymptomatic in 
immunocompetent people; however, in immunocom-
promised people they become fatal [1]. Opportunistic 
parasitic infections, including worms and protozoa, 
are neglected tropical diseases that are targeted by the 
sustainable development goals to be eliminated by 
2030 [2,3].
Human immunodeficiency virus (HIV) infection 
causes acquired immunodeficiency syndrome (AIDS), 
which is a complicated disease in humans, and sup-
presses the immune system [4,5]. Opportunistic par-
asitic infections are one of the most common health 
problems in patients with HIV/AIDS. The presence 
of opportunistic parasitic infections in HIV sufferers 
indicate that they are in the phase of AIDS. Most of 
these infections are severe, and often contribute to the 
death of infected individuals [4-7]. Thus, early detec-
tion and treatment need to be carried out to ensure 
adequate management [8-10].
The first case of HIV/AIDS in Indonesia was 
reported in Bali in 1987, while in Sulawesi it was 
reported in 2012 [11]. It is estimated that every min-
ute, one Indonesian is infected with HIV/AIDS. 
The age group most affected is the productive age, 
i.e., 20-39 years, with a case fatality rate of 18.7% [11].
Among the opportunistic infections, parasites 
are the most common causative pathogens that affect 
the morbidity and mortality of patients infected with 
HIV/AIDS. Parasites can trigger an immune response 
to infect the respiratory tract, digestive tract, blood, 
brain, and other organs. The parasitic species that most 
often cause the opportunistic infections in the human 
body are Toxoplasma gondii, Cryptosporidium parvum, 
Isospora belli, Cyclospora cayetanensis, Microsporidia, 
Cryptococcus neoformans, Pneumocystis carinii or 
jiroveci, and Entamoeba [12-14].
Among the parasitic opportunistic infections 
(POIs), cryptosporidiosis, isosporiasis, and microspo-
ridiosis are the main enteric POIs, and toxoplasmo-
sis and leishmaniasis are the main systemic POIs 
reported in HIV-infected patients [2,4,6]. Another 
study described the opportunistic parasites C. parvum, 
Cyclospora cayetanensis, I. belli, and Microsporidia 
spp. as a common feature in HIV/AIDS patients, 
especially when the CD4+ T cell counts fall below 
200 cells/μL [4].
Opportunistic infection has been catego-
rized according to CD4+ counts as follows: 
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Mycobacterium tuberculosis was found in all CD4+ 
counts; Coccidioidomycosis was in CD4+ counts 
<250 cells/mm3; Pneumocystis jiroveci pneumonia 
and mucocutaneous candidiasis were in CD4+ counts 
<200 cells/mm3; Histoplasma capsulatum was in CD4+ 
counts <150 cells/mm3; C. neoformans, Cryptosporidiosis, 
Herpes simplex viruses, Microsporidiosis were in 
CD4+ counts <100 cells/mm3; and C. neoformans, 
Cryptosporidiosis, and Cytomegalovirus, T. gondii, and 
Bartonellosis were in CD4+ count <50 cells/mm3 [15].
UNAIDS data on the current HIV/AIDS situ-
ation have reported that globally 1.7 million people 
became newly infected with HIV by the end of 2018, 
37.9 million people globally were living with HIV 
by the end of 2018, and almost 1 million people died 
from AIDS-related illnesses. Opportunistic parasitic 
infection is a major cause of morbidity and mortality 
worldwide; most of them are emerging diseases [11].
An understanding of parasites that cause oppor-
tunistic infections in HIV/AIDS is required, especially 
in the decades, where HIV has caused a huge burden 
on global wealth and health. Thus, early detection and 
prompt treatment can be established to reduce deaths 
due to HIV/AIDS.
This reivew presents an overview of the etiologic 
agents of opportunistic infections among countries, 
epidemiology and prevalence, lifecycle, risk factors, 
examination methods, and treatments.
Clinically Relevant Intestinal Parasitic 
Infections
Parasitic infections in the digestive tract remain 
a burden for people infected with HIV, even in the era 
of the use of antiretroviral therapy (ART) [16]. CD4+ 
count in HIV patients are risk factors for opportunistic 
parasitic infections with manifestations of diarrhea [4].
In AIDS with severe immunosuppression, com-
mensal intestinal parasites become opportunistic, 
causing fatal prognostic diarrheal diseases in HIV 
patients. There are various species of parasites that 
cause diarrhea in HIV patients, such as C. parvum, 
Giardia lamblia, Microsporidia, and I. belli [13,14]. 
Some studies have reported that the most common 
intestinal parasitic species found in diarrhea experi-
enced by HIV patients are Blastocyst spp., C. parvum, 
Microsporidia, S. stercoralis, and O. viverrini [17]. 
There are also parasites known as classical opportu-
nistic agents, which are C. parvum, I. belli, C. caye-
tanensis, and Microsporidia [17].
A study reported that the introduction of the highly 
active anti-retroviral therapy regimen as the main treat-
ment for HIV has led to the occurrence of immune 
reconstitution inflammatory syndrome in opportunistic 
parasitic infections such as C. parvum [12].
Risk Factors for Opportunistic Parasitic 
Infection
Risk factors for HIV/AIDS are man [7,18,19], 
unemployment, living in urban area, and marriage [19]. 
However, other studies have found that women, house-
wives, and trading are risk factors for HIV/AIDS [19].
In HIV/AIDS patients, the rate of a particular 
intestinal parasitic infection depends on the endemic-
ity of the parasite in the community [7]. Intestinal par-
asites are widely distributed partly due to the low level 
of environmental and personal hygiene, fecal contam-
ination of food and drinking water, and poor hous-
ing facilities [4]. Assessing current CD4+ cell count 
helps identify the status of intestinal parasite infection 
among HIV patients [20].
Risk factors associated with a higher prev-
alence of opportunistic parasitic infection among 
HIV patients were low CD4+ counts, persistent diar-
rhea, poor living conditions, and poor nutrition [20]. 
Another research reported ART status, CD4+ T-cell 
count, diarrhea, work status, and access to a toilet as 
the risk factors associated with a higher prevalence of 
intestinal parasites among HIV patients [19].
The association between the CD4+ T-cell 
count and intestinal protozoa infection has also been 
reported in the previous studies from Ethiopia, India, 
and Malaysia [4,18]. Stage of HIV/AIDS, CD4+ 
count, ART adherence, and hemoglobin level has also 
been reported as risk factors for opportunistic para-
sitic infections. CD4+ count <200 cells/μL poses the 
greatest risk for opportunistic infection in HIV/AIDS 
patients [19].
Risk factors for C. cayetanensis are consump-
tion of raw fruits and vegetables, drinking untreated 
water, swimming in rivers, contact with soil or ani-
mals, agricultural work, and poor hygiene [21]. Risk 
factors for C. parvum infection are non-Hodgkin’s 
lymphoma, leukemia, lymphoproliferative disease, 
malnutrition, immunosuppressive drugs, cancers, and 
hemodialysis [22]. Risk factors for I. belli include lym-
phoblastic leukemia, adult T-cell leukemia, Hodgkin’s 
disease, non-Hodgkin’s lymphoma, lymphoprolifera-
tive disorders, renal transplant, and liver transplant [22].
Risk factors associated with Microsporidia 
infection include sexual relations between men, use 
of intravenous drugs, exposure to swampy water or 
irrigated areas, exposure to water with feces, and 
use of swimming pools and hot tubs, or contact with 
water [23]. Research shows that Microsporidia is 
often found in patients with malignancy and diabetes 
mellitus [22].
Intestinal parasitism during pregnancy may affect 
the health of pregnant women and their offspring [24]. 
However, only few studies have described the effects 
of intestinal parasitism on pregnancy outcomes [25]. 
Parasitic infection(s) during pregnancy have been 
associated with increased risk of pregnancy complica-
tions and adverse outcomes [25]. Low weight during 
pregnancy, poor fetal growth, low birth weight, and 
preterm birth are some of the consequences of intesti-
nal parasitic infection during pregnancy [24].
One of the intestinal parasitic infections that had a 
significant consequence on pregnant women and their 
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offspring was Blastocystis hominis, which recorded 
15% (50/331) prevalence among pregnant women in 
Bogota, Colombia [24]. C. parvum and I. belli can be 
transmitted from human to human through anal-oral 
contact [26]. Another research stated that marital sta-
tus was not implicated as a determinant of the occur-
rence of enteric protozoal infection among the study 
subjects [18].
C. cayetanensis
C. cayetanensis was first discovered in the form 
of blue-green algae, or coccidian-like body, or cyano-
bacterium-like body. This form of C. cayetanensis is 
without organelle, but has a membrane, and is larger in 
size than C. parvum. Traced phylogenetically, C. cay-
etanensis is closely related to the genus Eimeria [27].
C. cayetanensis oocysts are found in raspber-
ries and water sources that have the potential to cause 
epidemics [27]. In the lifecycle of C. cayetanensis, 
oocysts must be in the form of sporocysts outside 
the human body before becoming infective [28]. The 
lifecycle of C. cayetanensis (Figure-1) starts from 
the release of oocysts in feces. After about 7 days of 
oocyst sporulation, it becomes an infective form. The 
sporocysts release sporozoites that infect the duode-
num and jejunum, and then the sporozoites undergo 
asexual and sexual multiplication to produce oocysts 
that are non-sporulating in the host environment [27].
Patients suspected of having C. cayetanensis 
infection may present with symptoms of flu-like ill-
ness, diarrhea, anorexia, nausea, flatulence, fatigue, 
abdominal cramps, and mild fever accompanied 
by weight loss. Severe symptoms include ventricu-
lar dysrhythmia, biliary disease, Reiter syndrome, 
Guillain-Barre syndrome, ocular inflammation, sterile 
urethritis, and oligoarthritis [27].
Envirochek capsules and Hannifin filters can 
be used to get C. cayetanensis oocysts from water 
sources, while getting C. cayetanensis in the food can 
be performed through lectin (agglutination of wheat 
germ) coated with paramagnetic beads [29].
Parasitological diagnosis of C. cayetanensis is 
confirmed by finding spherical forms containing mor-
ula (oocyst) in the wet mount and stained preparations, 
including modified acid-fast stain, Giemsa, trichrome, 
Gram-chromotrope, and Kinyoun staining [27]. The 
method of fecal examination used for the diagnosis 
of opportunistic parasitic infections includes direct 
saline, iodine wet mount, formalin-ether sedimenta-
tion concentration, and modified Ziehl–Neelsen [30]. 
Molecular techniques using the PCR method of inter-
nally transcribed spacer 2 of DNA were performed to 
obtain a segment of 116 bp from the sample [27].
The first choice of treatment for C. cayetan-
ensis infection is trimethoprim-sulfamethoxazole 
(TMP-SMX) 25 mg/kg body weight for 3 days, other 
alternative treatments are ciprofloxacin, norfloxacin, 
azithromycin, tinidazole, nalidixic acid, diloxanide 
furoate, and quinacrine [27].
C. parvum
C. parvum is an intracellular obligate parasite [31]. 
There are 31 species of C. parvum [32]. The parasite did 
not only cause diarrhea but it also manifested several 
symptoms in the lungs of HIV/AIDS patients [26].
Coccidian parasites (Cryptosporidium spp., 
I. belli, and Cyclospora spp.) are the most common 
enteric parasites in immunocompromised patients, 
which can cause severe, deadly diarrhea. The prev-
alence rate of cryptosporidiosis among diarrhea 
patients with HIV/AIDS is significantly higher than 
10%. Immunocompromised diarrhea tends to be 
chronic and causes increased morbidity and mortality 
in these patients [33].
Cryptosporidiosis is a zoonotic disease; livestock, 
wild animals, pets, and rats may play an important 
role as the reservoir. It can be transmitted from human 
to human through anal-oral contact or from humans to 
animals through fecal-oral [26]. Besides HIV/AIDS, 
individuals with immunodeficiency conditions, such 
as those who have received chemotherapy, organ, or 
bone marrow transplants, and malnutrition and dia-
betes mellitus patients are also prone to infection by 
C. parvum. Other risk factors for C. parvum infection 
are non-Hodgkin’s lymphoma, leukemia, lymphopro-
liferative disease, immunosuppressive drugs, cancers, 
and hemodialysis [22].
The lifecycle of C. parvum (Figure-2) begins 
by ingestion of oocysts from contaminated water or 
food [34]. The parasite invades the intestinal epithe-
lium, where it completes its lifecycle in the cytoplasm 
of the enterocyst. Unsporulated oocysts are excreted in 
feces and mature outside the host, where they develop 
into the infective sporulated oocysts [22]. C. parvum 
Figure-1: Life cycle of Cyclospora cayetanensis. Figure-2: Life cycle of Cryptosporidium parvum.
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has a single host lifecycle that is asexual and sexual 
and occurs in the intestines of infected hosts [34].
Diarrhea caused by C. parvum in immunocom-
promised patients may be disseminated, thus causing 
increased mortality rate in HIV/AIDS [14]. C. parvum 
infection affects multiple organ functions, particularly 
the respiratory, pancreatic, and biliary tracts [35].
Microscopic examination is required to confirm 
the diagnosis of C. parvum infection. It can be per-
formed by floatation, concentration, and Sheather’s 
sugar solution [36]. Further examination can be per-
formed through immunofluorescence assay (IFA), 
antigen (immunoassay), and polymerase chain reac-
tion (PCR) [35,37]. Various rapid diagnostic tests 
(RDT) are available including Immunocard STAT, 
RIDA check, Quick check, Giardia-crypto duo-strip, 
and RDT, which generally combine the examination 
of C. parvum with G. lamblia [38].
There are no commercially available human 
vaccines for C. parvum, although numerous can-
didate attenuated and DNA vaccines have been 
identified [35,37]. Oocysts of C. parvum have acid-
fast (lipid-rich) walls, which are resistant to environ-
mental insults and to gastrointestinal acids, proteases, 
and bile [37]. Prevention strategy must focus on 
proper hygiene and clean sanitary conditions to mini-
mize Cryptosporidium outbreaks [35].
The pattern of opportunistic parasite species that 
is often found in people with HIV/AIDS in a coun-
try actually describes the opportunistic parasite spe-
cies that exist in the country’s natural environment. 
This is due to suppression of the immune system in 
people with HIV/AIDS, making the individual vul-
nerable to infections of opportunistic parasites in their 
environment.
Many research had been reported different pro-
tozoal agents that caused diarrheal disease in HIV/
AIDS. The opportunistic parasite infection pattern in 
each country is different (Table-1).  
Microsporidia
Microsporidia is an intracellular obligate organ-
ism classified as eukaryotes because it has membranes, 
intra-cytoplasmic membrane systems, and chromo-
some separation in mitotic-spindles, and is closest to 
fungus because it contains chitin on the spore wall, 
but is more discussed as protozoa. Microsporidia has 
small, resistant spores; the phylum consists of 170 
genera and 1300 species [39].
The lifecycle of Microsporidia consists of 
three phases, termed infective, proliferative, and 
sporogony [39,40]. Microsporidia can be transmitted 
through urine, soil, water, and food [41].
Microsporidia infection may affect muscles, 
intestines, gall bladder, liver, kidneys, eyes, brain, 
lungs, skin, and the nasal sinuses. Bowel Microsporidia 
most commonly occur in 30–50% of AIDS patients 
with chronic diarrhea [40].
The diagnosis of Microsporidia is determined 
by the use of several methods such as Giemsa, Gram, 
and/or Ziehl–Neelsen staining, to find spores contain-
ing polar filaments [39]. Touch preps and smears from 
biopsy, eye scraping, tissue specimens, and aspirations 
stained with Gram, Giemsa, or Trichrome can be iden-
tified in urine, stool, and duodenal fluid samples [39].
There are variations in Microsporidia, which 
help identify genus and species; they include the num-
ber of spores produced in sporogony, the way spores 
are produced, host interactions with parasites, mor-
phological characteristics of developmental stages, 
nucleation, the place where infection occurs, and sero-
logical and molecular diagnosis [40].
Molecular examination methods for diagnos-
ing Microsporidia include fluorescence, electron 
microscopy,  ELISA,  and  Western  blotting  [39]. 
Immunofluorescence tests using the chitin binding 
Fluorochrome Uvitex 2B, Fungifluor, Calcofluor 
white, and Fungiqual A are available for detecting 
Table-1: Different protozoal agents in diarrheal disease based on geographical regions.
Parasite species References Published year Country 
Cryptosporidium parvum, Cyclospora cayetanensis, Isospora belli and 
Microsporidium
[1] 2016 Cameroon
Cryptosporidium parvum, Isospora belli, Giardia lamblia, Entamoeba 
histolytica, Iodamoeba butschlii
[3] 2015 India
Cryptosporidium parvum, Isospora belli, Cyclospora, Microsporidia, 
Entamoeba histolytica
[4] 2016 India
Cryptosporidium parvum, Giardia lamblia, Leishmania tropica, 
Pneumocystis carinii
[6] 2016 Egypt
Cryptosporidium parvum, Entamoeba histolytica, Isospora belli, Taenia, 
Giardia lamblia
[7] 2016 India
Cryptosporidium spp., Cystoisospora belli, Cyclospora cayetanensis, 
Giardia lamblia, Entamoeba histolytica, Blastocystis hominis, Microsporidia
[11] 2015 India
Blastocyst hominis, Cryptosporidium parvum, Microsporidia, Strongyloides 
stercoralis, Opisthorchis viverrini, Entamoeba dispar, Giardia lamblia
[13] 2014 Laos
Cryptosporidium parvum, Isospora belli, Blastocyst hominis [14] 2018 Ethiopia
Cryptosporidium parvum, Isospora belli, Microsporidia, Cyclospora 
cayetanensis, Giardia lamblia
[19] 2015 Ethiopia
Cryptosporidium parvum, Enterocytozoon bieneusi, Giardia lamblia, 
Sarcocystis, Blastocyst hominis 
[20] 2013 Iran
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microsporidial infection. Monoplex PCR can also be 
used to detect Microsporidia [22].
I. belli
Cystoisospora belli is a synonym for I. belli, 
which belongs to the family Eimeridae, consisting of 
15 species. Cystoisospora or I. belli is only found in 
humans, whereas other species such as Cystoisospora 
felis, Cystoisospora canis, and Cystoisospora suis are 
present in animals [42].
Coccidian parasites (Cryptosporidium spp., 
I. belli, and Cyclospora spp.) are the most common 
enteric parasites in immunocompromised patients, 
which can cause severe, deadly diarrhea [33]. Of the 
eight chronic cases of isosporiasis persisted with stan-
dard antimicrobial therapy and secondary prophy-
laxis, four patients died, two remained symptomatic, 
and two recovered. Mortality from I. belli infection in 
HIV/AIDS is high, especially at low CD4 + levels [43].
Human-to-human transmission is impossible 
in I. belli infection as the formation of an infective 
stage requires an external environment. The lifecycle 
of I. belli (Figure-3) begins when oocysts released in 
the non-infective I. belli become infective after being 
outside the body or in the environment. I. belli is not 
a zoonotic disease because humans are the only defin-
itive host; there is no intermediate host. Transmission 
occurs through anal-oral contact, contaminated water, 
and food [44].
The method of the examination for diagnosing 
I. belli is the same as that for C. parvum [44]. The treat-
ment for I. Belli infection is TMP/SMX regiment [44]. 
The low prevalence and variations of isosporiasis 
could be due to the wide use of anti-opportunistic 
infection medications, ART, and geographic differ-
ences. Furthermore, it has been suggested that co-tri-
moxazole prophylaxis given for other infections in 
AIDS cases, and the low number of oocysts excreted 
is possible explanations for the observed low preva-
lence of isosporiasis [18].
Sarcocystis
HIV infection has altered both the epidemiol-
ogy and outcome of enteric opportunistic parasitic 
infections. A study in Iran showed that the most com-
mon opportunistic and non-opportunistic pathogens 
were C. parvum, followed by E. bieneusi, G. lamblia, 
Sarcocystis spp., and B. hominis [41]. Research in 
Malaysia also showed that Sarcocystis is a potentially 
infectious disease in travelers [45]. Infection with 
intestinal sarcocystosis causes a self-limiting disease 
characterized by nausea, abdominal pain, and diarrhea 
in immunocompetent persons whereas in HIV/AIDS 
patients it could cause myopathy [46].
Sarcocystis was first discovered in pork meat. 
In the beginning, it was named sarcosporidium as 
the culture media produced hyphae and mycelium 
before clearer structure could be seen microscopically. 
Sarcocystis species infection is rare [45].
The morphology of Sarcocystis oocyst resem-
bles that of I. belli, while the sporocysts are larger 
than those of C. parvum [42]. Intermediate hosts of 
Sarcocystis are herbivores, mammals, reptiles, birds, 
fish, and humans. The definitive host contains intes-
tinal stage parasites, which vary from carnivorous 
animals to humans [44]. Transmission of Sarcocystis 
infection occurs from the consumption of raw meat 
containing the sarcocysts or ingesting water or food 
contaminated with the oocysts [44].
Sarcocystis hominis is found in cattle, while 
S. suihominis is found in pigs [44,45]. The clinical 
manifestation of the infection is generally asymptom-
atic; symptoms may involve diarrhea, abdominal pain, 
and weight loss [44]. Other symptoms include fever, 
headache, myalgia, and myositis in severe conditions 
caused by the development of intramuscular cysts. 
Clinical symptoms caused by S. suihominis are more 
severe than those of S. hominis. Presumptive diag-
nosis for Sarcocystis is done by taking into account 
any history of recent travel to tropical areas, increased 
serum enzymes, and eosinophilia [45].
The method of the diagnosis for Sarcocystis is 
similar to that for C. parvum and I. belli; muscle biopsy 
needs to be performed when myalgia is found [44]. The 
treatment of S. suihominis and S. hominis infections is 
with SMX-TMT, otherwise symptoms in the muscles are 
essentially treated with anti-inflammatory drugs [45].
B. hominis
B. hominis is a eukaryotic, cosmopolitan para-
site, infecting various animals ranging from birds, pigs, 
horses, amphibians, reptiles, to insects [47]. B. hominis, 
which is commonly found in the intestinal tract, can 
lead to gastrointestinal symptoms such as diarrhea, 
nausea, abdominal pain, vomiting, and bloating. The 
prevalence of B. hominis is 1.5-10% in developed 
countries, where it can cause deterioration of health 
in immune-compromised patients. B. hominis can be 
harmful to HIV-positive patients or organ-transplant 
patients who receive immunosuppressive agents [48].
The morphology of B. hominis varies between 
the cystic, vacuolar, multi-vacuolar, granular, and 
amoeboid forms. The pathognomonic characteristic 
of B. hominis is the large centralized vacuoles [47]. 
The protozoa are commonly found in individual feces Figure-3: Life cycle of Isospora belli.
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without any symptoms, which show this parasite is of 
low pathogenicity [47].
B. hominis infects the cecum and colon. The prev-
alence of B. hominis ranges from 1.6 to 50%. The prev-
alence of B. hominis infection was 72% in people with 
HIV/AIDS in Indonesia [47]. Research in the United 
States and Paris showed that B. hominis infections were 
more frequent compared to Entamoeba histolytica, 
G. lamblia, and C. parvumin HIV/AIDS patients [49].
The lifecycle of B. hominis starts from the sol-
id-walled cysts in feces, infects the host to proceed to 
asexual multiplication, becomes vacuolar form, arranges 
a multi-vacuolar or amoeboid form, and becomes a 
pre-cyst. Further development of the pre-cyst can be a 
thick- or thin-walled cyst. Thin-walled cysts play a role 
in the auto-infection process, while thick-walled ones 
will be released in the stool and are the infective form 
later in fecal-oral or external transmission [47,49].
Preferred therapies for B. hominis infections are 
emetin, furazolidone, metronidazole, and TMP-SMX. 
Metronidazole at a dose of 250-750 mg 3 times a day 
for 5 days or 2 g/day for 5 days is a therapeutic reg-
imen to treat B. hominis infection in immunocompe-
tent patients with symptoms of diarrhea, abdominal 
pain, and nausea [47]. In HIV/AIDS patients, treat-
ment with furoximin becomes the choice to eradicate 
B. hominis [47]. Another study using a 0.5-1 g met-
ronidazole regimen for 7-10 days, showed relieve of 
symptoms accompanied by a diminished concentra-
tion of B. hominis in feces [47].
C. neoformans
C. neoformans is a fungus, which is commonly 
found in urban areas. It may infect immunocompro-
mised individuals who ingest the spores. In individuals 
with adequate immune systems, C. neoformans vars 
gatti is generally asymptomatic, however, in immuno-
compromised individuals, it becomes a major cause of 
fatal neurological symptoms, such as meningitis [50]. 
Risk factors for C. neoformans infection include patients 
undergoing organ transplants and other long-term immu-
nosuppressive therapy [50,51]. Capsules, melanin, and 
urease phospholipase activity are the virulence factors 
of C. neoformans, which play an important role in envi-
ronmental survival [51,52]. C. neoformans can cause 
chronic diarrhea in non-HIV infected patients. Chronic 
diarrhea caused by C. neoformans is less frequent, and 
clinical suspicion is required to determine diagnosis [53].
The main treatment for infection caused by 
C. neoformans is amphotericin as a secondary metab-
olite of Streptomyces nodosus. For the treatment of 
C. neoformans infection in HIV/AIDS patients, HIV 
protease inhibitor such as indinavir may be used [50].
Diagnosis and Supporting Examination for 
Detecting Diarrhea-causing Parasites in 
HIV/AIDS Patients
The examination methods for diagnosing intes-
tinal parasitic infections in patients with HIV are 
selected based on the organism. The methods include 
formalin-ethyl concentration technique for protozoa 
and worms, modified acid-fast staining for coccidian 
that cause classical opportunistic infections (C. par-
vum, I. belli, C. cayetanensis, and S. hominis), whereas 
microspora examination is done with Trichrome stain-
ing [17,18]. Stool samples were examined in iodine 
preparation for the detection of protozoan oocysts 
and cysts. Permanent stained smears are performed 
with modified Ziehl–Neelsen staining (Cold Method) 
for the detection of oocysts of Cryptosporidium, 
Isospora, and Cyclospora [10]. Simple direct, con-
centrated, and stained smear examination of stool can 
help in the identification of enteric parasites in major-
ity of patients [7].
Diagnostic Molecular Methods for 
Opportunistic Parasitic Infections
After the discovery of nucleic acid-based detec-
tion, the multiplex real-time PCR method has been 
applied in diagnosing intestinal parasites in the 
Netherlands. The advantage of this method of detec-
tion and quantification of parasite-specific DNA 
are that it is very sensitive, thus increases detec-
tion of intestinal parasites, namely, Giardia lamblia 
and Cryptosporidium spp. [54]. Monoplex PCR is 
used to detect Microsporidia and Cryptosporidium, 
whereas multiplex PCR is used for G. lamblia, 
Cryptosporidium, Dientamoeba fragilis, and E. histo-
lytica [39]
Molecular diagnostic methods for C. parvum 
include lateral flow immunoassays, immunochro-
matographic assays, and direct fluorescent anti-
body tests. A TaqMan PCR assay targeting, the 18S 
ribosomal DNA (rDNA) has been found to detect 
Cryptosporidium species [22]. Molecular diagnostic 
methods for C. cayetanensis include autofluorescence 
under UV, epifluorescence microscopy, and DNA 
amplification using PCR. A real-time PCR target-
ing, the internal transcribed spacer two regions of the 
rRNA gene have also been used to examine I. belli 
DNA in fecal samples [22].
The PCR method is useful for determin-
ing Microsporidia species because there are 14 
Microsporidia species. In addition to the PCR 
method, the immunofluorescent-antibody test has 
the same sensitivity as PCR [22]. Sarcocystis can be 
detected using transmission electron microscopy [55]. 
The method of PCR- restriction fragment length poly-
morphism was used to amplify approximately 900 bp 
fragment at the 18S rRNA (SSU) gene, of which the 
restriction enzyme BclI was used for the identification 
of Sarcocystis species in Iran [56].
The diagnosis of B. hominis can be made using 
the methods of conventional, phase-contrast, and elec-
tron microscopies, cultivation, sero-diagnosis, and 
using molecular methods [57]. Blastocystis exhibits 
extensive genetic diversity, and this has been docu-
mented using numerous molecular techniques [22]. 
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PCR was performed using seven primer pairs targeting 
the SSU rDNA gene, and sequencing have been used 
to detect B. hominis in Iran. Multiplex PCR using two 
primer sets were tested (CN4-CN5) and the multiplex 
CNa70S-CNa70A/CNb49S-CNb-49A that amplified 
a specific product for C. neoformans and another for 
C. gattii are [58] already established [59].
Molecular diagnosis methods for the identification 
of Cyclospora oocysts are hampered by the lack of ani-
mal models and limited DNA sequence data. Techniques 
for fingerprint analysis and genotype discrimination are 
not available for C. cayetanensis; therefore, identifi-
cation using a microscope is still frequently used [21]. 
Microsporidia are difficult to detect because of their 
small size, their slowly infecting properties, and some-
times asymptomatic infection. Immunoblot, ELISA, and 
IFA using monoclonal and polyclonal antibodies also 
help serological examination for Microsporidia charac-
terization. However, serological testing cannot be relied 
on in people with HIV because of lack of immunity [23].
Simple India ink examination of the CSF has a 
70-90% sensitivity and cases that are negative on the 
India ink test, can be reliably diagnosed by detection of 
cryptococcal antigen. Antigen detection based on latex 
agglutination although sensitive and specific were never 
widely available in high-burden, resource-limited set-
tings. In the context of limited resources, development of 
a lateral flow assay (LFA; manufactured by IMMY) has 
been a major advancement. A second, semi-quantitative, 
lateral flow test is now in development by Biosynex and 
Institut Pasteur in Paris, France [60].
The association between intestinal parasitic infec-
tions and HIV infection has been well documented in 
many research [2,4,7,10,13,14,16,18,22,31,34,46, 61]. 
The prevalence of intestinal parasitic infections was 
varied depending on geographic and other factors 
such as CD4+ count, ART, prophylaxis, hygiene, 
and sanitation (Table-2) [1,4,7,9,11,12,14,19,33]. 
Different examination methods that have been used 
to investigate intestinal parasitic infections also 
Table-2: Prevalence, risk factors, and examination methods of opportunistic parasitic infection in HIV/AIDS patients 
based on geographical regions.
Prevalence 
of intestinal 
parasitic infection 
Risk factors Examination methods References Published 
year
Country 
30.6% CD 4 count<200 cell/µl Wet mount, formol–ether 
sedimentation and modified 
Ziehl–Neelsen techniques
[19] 2015 Ethiopia
32.5% CD 4 count<200 cell/µl Direct wet-mounts (normal 
saline, Lugol’s iodine), formol-
ether concentration, modified 
Ziehl–Neelsen, modified 
trichrome staining 
[11]  2015 India
45% CD 4 count<200 cell/µl Direct microscopy by saline 
wet mount, iodine wet mount, 
modified Ziehl–Neelsen (ZN)
[7] 2016 India
45% CD 4 count 200-500 
cell/ µl, Health education 
regarding personal 
hygiene, regular 
de-worming
Direct wet mount, formalin 
ether concentration,  
modified Ziehl–Neelsen (ZN)
[33] 2016 Laos
 49% Age group 20-30 years, 
geographis, personal 
hygiene, sanitary 
habits, method of stool 
examination, immune 
status
Iodine, saline, formalin ether 
concentration
[4] 2016 India
pre ART 84.6%, 
ART 82.3%
CD 4 count<200 cell/µl Wet mount, Iodine mount, 
Katokatz, formalin ether 
concentration, modified Ziehl–
Neelsen (ZN), Modified field 
staining 
[1]  2016 Cameroon
85% CD 4 count<200 cell/µl Direct wet mount (saline 
and Lugol’s Iodine), formalin 
ether concentration, modified 
Ziehl–Neelsen (ZN), Trichrome 
staining, Iron Hematoxylin 
staining
[12] 2016 India
28.18% CD 4 count<500 cell/µl, 
Presence of domestic 
animals, poor sanitation
Direct wet mount, formol-
ether sedimentation modified 
Ziehl-Neelsen 
[14]  2018 Ethiopia
26.4% CD 4 count<200 cell/µl, 
ART, Trimethoprim-
sulfamethoxazole (TS) 
prophylaxis
Direct wet mount, Ritchie 
and modified Ziehl–Neelsen 
techniques, Coproantigen
[9] 2017 Mozambique
ART=Antiretroviral therapy, HIV=Human immunodeficiency virus, AIDS=Acquired immunodeficiency syndrome
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influenced the prevalence of the diseases. Various 
molecular diagnosis methods have been used for 
detection of opportunistic parasitic infections 
(Table-3) [22,23,39,54,55,56,57,58,59].
Treatment for Opportunistic Parasitic 
Infections
The treatment for B. hominis is metro-
nidazole [57]. The drugs of choice for cryptospo-
ridiosis include paromomycin, azithromycin, and 
nitazoxanide [22]. Effective treatment for C. caye-
tanensis infection is TMP-SMX; the alternative ther-
apy is nitazoxanide, or ciprofloxacin. Treatment for 
I. belli infection is co-trimoxazole for 7-10 days [22]. 
Albendazole has been shown to be effective in treat-
ing infections caused by Microsporidia. Other drugs 
of choice for Microsporida include nitazoxanide and 
furazolidone [22]. Amphotericin B plus flucytosine 
rapid clearance is used for C. neoformans [60].
Conclusion and Future Perspective
Opportunistic parasitic infections are the most 
common health problems in patients with HIV/AIDS. 
Opportunistic intestinal parasitic infections will 
increase in the future due to the increasing incidence 
of HIV/AIDS in the population. However, early detec-
tion, using molecular diagnosis methods, of intesti-
nal parasitic infections in HIV seropositive patients, 
appropriate initial treatment in new cases, and 
maintenance therapy in chronic cases will improve the 
quality of life of people infected with HIV.
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